Call for poster presentation at the 1st Pan American Congress of Autism, Fragile X Syndrome and Neurodevelopmental Disorders:

Within the framework of the activities of the 1st Pan American Congress of Autism, Fragile X Syndrome and Neurodevelopmental Disorders, the call to participate in the presentation of scientific posters is open

1. About the presentation of posters:

The Congress will take place in Cartagena de Indias, Colombia, during the first half of 2021.

The purpose of the Congress is to update professionals on basic concepts of neurodevelopmental disorders, as well as comorbidities, diagnosis, treatments and new pharmacological, therapeutic, technological, genetic and clinical advances. With the presentation of the poster format, the aim is to enhance scientific communication and dissemination of research projects.

The presentation of posters shall have only the in-person modality:

Posters will be exhibited from the morning of the first day of the Congress to the afternoon of the last day. At least one of the authors must be registered and ready to present the poster, answer questions and enter into dialogue with the participants, in a period of two hours that will be communicated to the authors.

Proposals will have to go through an evaluation process, which will be based on a summary/abstract. The evaluation will be carried out by a Scientific Evaluation Committee. Under no circumstances a poster proposal may be accepted if it cannot be presented in person by the authors themselves during the Congress.

2. Selection process:

The summary/abstract of the poster (up to 300 words) must be accompanied by the following information:

1. Poster title

2. Full name of the author(s).

3. The name of the author submitting must be underlined

4. Institution or entity to which the authors are affiliated to

5. Email and contact phone number

6. Keywords (4-6)

7. Specify the area: scientific or clinical

The deadline for submission of poster summaries is still TBD. Abstracts must be sent via email to copa.axt@gmail.com

The Scientific Committee will evaluate the proposals and communicate to the authors, by e-mail, their acceptance or rejection decision.

The criteria to be evaluated are: Consistency and relevance with the contents of the Congress

Once the poster summary is accepted, the authors can proceed to print the poster. The printed version must have the following dimensions: 122 cm (high) by 92 (wide), and will be mounted in the exhibition space defined on Thursday, April 16^th (before the official opening).

3. Recognition and awards:

The posters will be evaluated by the scientific evaluation committee during the two-hour period assigned for presentation. Once the poster presentation session is completed, the 3 most outstanding works will be announced. The winners will receive a certificate of recognition and the reimbursement of the total registration cost.

Extended versions of the presented work will be published by Revista de Neurología – Spain

Scientific Evaluation Committee:

1. Bibiana M Restrepo, MD (USA)

2. Rosa D Rodriguez, MD (USA)

3. Denise Medici, PhD (Spain)

4. Leticia Boada, PhD (Spain)

5. Stephen Noctor, PhD (USA)

6. César Payán, MD, PhD (Colombia)

Dr. Miquelajauregui is an assistant professor at the Institute of Neurobiology of the University of Puerto Rico at the Medical Sciences Campus. Research in Dr. Miquelajauregui’s lab aims to understand brain development processes from embryonic to postnatal stages and to characterize alterations caused by genetic and environmental factors using rodent models of neurodevelopmental disorders. She also currently conducts a longitudinal study that tracks infants under 3 months to 18 months of age trying to describe the development trajectories of high-risk populations using cognitive and physiological measures.

Doctor Restrepo is a specialist in neurodevelopmental disorders. She graduated from Tufts University in Boston. She obtained her pediatrician degree from the University of Texas and graduated as a physician at the Universidad Tecnologica de Pereira, Colombia. She is currently an associate clinical professor in the Department of Pediatrics at the University of California Davis School of Medicine and director of ECHO Autism at the University of California Davis MIND Institute

Dr. Restrepo’s work focuses on early detection, diagnosis and management of neurodevelopmental problems, specifically autism spectrum disorder. She is particularly passionate about strengthening collaboration between professionals and therapists in addition to participating in the teaching of the new generation of doctors and leaders in the field of neuro-disabilities.

Dr. Tassone received her diploma as a Bachelor in Biology from the University of Rome and a PhD in molecular biology from the Catholic University of Rome (Italy) in 1992 for her studies on Down syndrome. During her postdoctoral fellowship, first at the Eleanor Roosevelt Institute in Denver, Colorado, and then at the University of Colorado Health Science Center, she continued to work on identifying genes involved in Down syndrome and began to focus on the molecular basis that leads to fragile X syndrome and autism spectrum disorders. In 2000, she moved to the University of California, Davis, and focused her research on neurodevelopmental disorders, including FXS and associated disorders, ASD and deletion 22q11.2 syndrome. She is a professor in the Department of Biochemistry and Molecular Medicine at the University of California, Davis School of Medicine and a researcher at the MIND Institute. Her experience is in regulating transcriptional and translational genes, particularly the FMR1 gene.